Inherited Thrombophilia and the Eye

REFERENCES

• Ben-Ami R, Zeltser D, Leibowitz I, Berliner S A. Retinal artery occlusion in a patient with factor V Leiden and prothrombin G20210A mutations. Blood Coagul Fibrinolysis 2002; 13(1)57–59
   Google Scholar
• Bertram B, Remky A, Arend O, Wolf S, Reim M. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol 1995; 4(6)332–335
   Google Scholar
• Brown K, Luddington R, Williamson D, Baker P, Baglin T. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene. Br J Haematol 1997; 98(4)907–909
   Google Scholar
• Cattaneo M. Hyperhomocysteinemia and venous thromboembolism. Semin Thromb Hemost 2006; 32(7)716–723
   PubMed Web of Science ®Google Scholar
• Chung I, Lip G Y. Virchow's triad revisited: blood constituents. Pathophysiol Haemost Thromb 2003; 33(5–6)449–454
   Google Scholar
• Ciardella A P, Yannuzzi L A, Freund K B, Di Michele D, Nejat M, De Rosa J T, et al. Factor V Leiden, activated protein C resistance, and retinal vein occlusion. Retina 1998; 18(4)308–315
   Google Scholar
• Clemetson K J. A short history of platelet glycoprotein Ib complex. Thromb Haemost 2007; 98(1)63–68
   Google Scholar
• Clouse L H, Comp P C. The regulation of hemostasis: the protein C system. N Engl J Med 1986; 314(20)1298–1304
   PubMed Web of Science ®Google Scholar
• Comp P C, Nixon R R, Cooper M R, Esmon C T. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74(6)2082–2088
   PubMed Web of Science ®Google Scholar
• Crowther M A, Kelton J G. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med 2003; 138(2)128–134
   PubMed Web of Science ®Google Scholar
• Dahlback B, Carlsson M, Svensson P J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993; 90(3)1004–1008
   PubMed Web of Science ®Google Scholar
• de Moerloose P, Boehlen F. Inherited thrombophilia in arterial disease: a selective review. Semin Hematol 2007; 44(2)106–113
   Google Scholar
• De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost 1998; 24(4)367–379
   Google Scholar
• De Stefano V, Finazzi G, Mannucci P M. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87(9)3531–3544
   PubMed Web of Science ®Google Scholar
• De Stefano V, Simioni P, Rossi E, Tormene D, Za T, Pagnan A, et al. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica 2006; 91(5)695–698
   Google Scholar
• Demirci F Y, Guney D B, Akarcay K, Kir N, Ozbek U, Sirma S, et al. Prevalence of factor V Leiden in patients with retinal vein occlusion. Acta Ophthalmol Scand 1999; 77(6)631–633
   Google Scholar
• Dhar-Munshi S, Ayliffe W H, Jayne D. Branch retinal arteriolar occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor. Arch Ophthalmol 1999; 117(7)971–973
   Google Scholar
• Eldibany M M, Caprini J A. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med 2007; 131(6)872–884
   PubMed Web of Science ®Google Scholar
• Fegan C D. Central retinal vein occlusion and thrombophilia. Eye 2002; 16(1)98–106
   Google Scholar
• Fong A C, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol 1993; 37(6)393–417
   Web of Science ®Google Scholar
• Garcia D A, Khamashta M A, Crowther M A. (2007). How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review. Blood 2007; 110(9)3122–3127
   Google Scholar
• Glueck C J, Wang P, Bell H, Rangaraj V, Goldenberg N. Nonarteritic anterior ischemic optic neuropathy: associations with homozygosity for the C677T methylenetetrahydrofolate reductase mutation. J Lab Clin Med 2004; 143(3)184–192
   PubMed Web of Science ®Google Scholar
• Glueck C J, Wang P, Bell H, Rangaraj V, Goldenberg N. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin Appl Thromb Hemost 2005; 11(4)375–389
   Google Scholar
• Golub B M, Sibony P A, Coller B S. Protein S deficiency associated with central retinal artery occlusion. Arch Ophthalmol 1990; 108(7)918
   Google Scholar
• Gottlieb J L, Blice J P, Mestichelli B, Konkle B A, Benson W E. Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults. Arch Ophthalmol 1998; 116(5)577–579
   Google Scholar
• Greiner K, Peetz D, Winkgen A, Prellwitz W, Pfeiffer N, Hafner G. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol 1999; 23(3)155–160
   Google Scholar
• Greven C M, Weaver R G, Owen J, Slusher M M. Protein S deficiency and bilateral branch retinal artery occlusion. Ophthalmology 1991; 98(1)33–34
   Google Scholar
• Hayreh S S, Zimmerman B, McCarthy M J, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001; 131(1)61–77
   PubMed Web of Science ®Google Scholar
• Janssen M C, den Heijer M, Cruysberg J R, Wollersheim H, Bredie S J. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005; 93(6)1021–1026
   PubMed Web of Science ®Google Scholar
• Kalayci D, Gurgey A, Guven D, Parlak H, Hasiripi H. Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion. Acta Ophthalmol Scand 1999; 77(6)622–624
   Google Scholar
• Lahey J M, Tunc M, Kearney J, Modlinski B, Koo H, Johnson R N, et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 2002; 109(1)126–131
   Google Scholar
• Larsson J. Central retinal artery occlusion in a patient homozygous for factor V Leiden. Am J Ophthalmol 2000; 129(6)816–817
   Google Scholar
• Larsson J, Hillarp A, Olafsdottir E, Bauer B. Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand 1999; 77(6)634–637
   Google Scholar
• Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996; 80(3)200–202
   Google Scholar
• Linna T. Prevalence of factor V Leiden in young adults with retinal vein occlusion. Thrombosis Haemostasis 1997; 77(1)214–216
   Google Scholar
• Marciniak E, Gockerman J P. Heparin-induced decrease in circulating antithrombin-III. Lancet 1977; 2(8038)581–584
   PubMed Web of Science ®Google Scholar
• Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai A P, et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 2001; 86(3)772–776
   Google Scholar
• Marcucci R, Bertini L, Liotta A A, Rogolino A, Antonucci E, Ilari I, et al. Activated protein C resistance is a risk factor for central retinal vein occlusion. Ann Ital Med Int 2000; 15(3)195–198
   Google Scholar
• Marcucci R, Sodi A, Giambene B, Liotta A A, Poli D, Mannini L, et al. Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion. Blood Coagul Fibrinolysis 2007; 18(4)321–326
   Google Scholar
• Nagy V, Steiber Z, Takacs L, Vereb G, Berta A, Bereczky Z, et al. Trombophilic screening for nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2006; 244(1)3–8
   Google Scholar
• Nelson M E, Talbot J F, Preston F E. Recurrent multiple-branch retinal arteriolar occlusions in a patient with protein C deficiency. Graefes Arch Clin Exp Ophthalmol 1989; 227(5)443–447
   Google Scholar
• Poort S R, Rosendaal F R, Reitsma P H, Bertina R M. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88(10)3698–3703
   PubMed Web of Science ®Google Scholar
• Price D T, Ridker P M. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997; 127(10)895–903
   PubMed Web of Science ®Google Scholar
• Rosendorff A, Dorfman D M. Activated protein C resistance and factor V Leiden: a review. Arch Pathol Lab Med 2007; 131(6)866–871
   Google Scholar
• Salomon O, Steinberg D M, Zivelin A, Gitel S, Dardik R, Rosenberg N, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999; 19(3)511–518
   PubMed Web of Science ®Google Scholar
• Shaw D M. Factor V Leiden: an overview. Clin Lab Sci 2006; 19(4)218–221
   Google Scholar
• Sofi F, Marcucci R, Abbate R, Gensini G F, Prisco D. Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. Am J Med 2007; 120(8)728–733
   Google Scholar
• Tekeli O, Gursel E, Buyurgan H. Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion. Acta Ophthalmol Scand 1999; 77(6)628–630
   Google Scholar
• Van Cott E M, Laposata M, Hartnett M E. Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis. Blood Coagul Fibrinolysis 2004; 15(5)393–397
   Google Scholar
• Williamson T H, Rumley A, Lowe G D. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 1996; 80(3)203–208
   Web of Science ®Google Scholar